
Corporate Action16 Sept 2026, 09:00 pm
Fredun Pharma Allots 271,200 Shares on Warrant Conversion
AI Summary
Fredun Pharmaceuticals Ltd announced the allotment of 271,200 equity shares following the conversion of 90,400 warrants. This action was approved by shareholders in an EGM on October 22, 2025, with warrants initially allotted on December 29, 2025. The conversion follows the payment of the balance consideration by warrant holders. The allotment, made on September 16, 2026, involved shares of face value Rs. 10/- each. The company also noted adjustments to outstanding warrants due to a 1:2 bonus issue, impacting future conversions and exercise considerations. The newly allotted shares will rank pari passu with existing equity shares.
Key Highlights
- 271,200 equity shares allotted upon warrant conversion.
- Conversion follows payment of balance consideration by warrant holders.
- Bonus issue adjusted entitlement for outstanding warrants.
- New shares will rank pari passu with existing equity.
- Preferential issue under SEBI ICDR Regulations 2018.
Price Impact
More from FREDUN